Extended Data Fig. 2: SARS-CoV-2 antibody levels in cancer patients with COVID-19.
From: CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
a, Relative levels of SARS-CoV-2 IgG (p = 0.02) and IgM (p = 0.0008) in non-cancer (n = 108) and cancer (n = 21) patients. b, Relative IgG levels in cancer patients. Each dot represents a cancer patient (Heme: Red; Solid: Yellow). (All) Significance determined by two-sided Mann Whitney test: *p < 0.05, ***p < 0.001. Median and 95% CI shown.
